Véronique Barbu

6.4k total citations
85 papers, 4.1k citations indexed

About

Véronique Barbu is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Véronique Barbu has authored 85 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 32 papers in Oncology and 20 papers in Hepatology. Recurrent topics in Véronique Barbu's work include Drug Transport and Resistance Mechanisms (25 papers), Pediatric Hepatobiliary Diseases and Treatments (24 papers) and Liver Disease Diagnosis and Treatment (11 papers). Véronique Barbu is often cited by papers focused on Drug Transport and Resistance Mechanisms (25 papers), Pediatric Hepatobiliary Diseases and Treatments (24 papers) and Liver Disease Diagnosis and Treatment (11 papers). Véronique Barbu collaborates with scholars based in France, United States and Tunisia. Véronique Barbu's co-authors include Chantal Housset, François Dautry, Dominique Wendum, Olivier Rosmorduc, Colette Rey, Christophe Corpechot, Raoul Poupon, Nils Kinnman, Raoul Poupon and Jacques Gielen and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Véronique Barbu

84 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Barbu France 35 1.5k 1.2k 1.1k 1.1k 963 85 4.1k
Shotaro Sakisaka Japan 33 806 0.5× 1.1k 0.9× 883 0.8× 1.4k 1.3× 1.2k 1.2× 181 3.9k
Hitoshi Kohno Japan 40 1.2k 0.8× 1.5k 1.2× 740 0.6× 1.9k 1.7× 1.0k 1.1× 135 5.2k
Siegfried Matern Germany 34 617 0.4× 1.1k 0.9× 1.5k 1.3× 1.1k 1.0× 1.2k 1.3× 79 3.8k
Kenneth Dorko United States 31 1.6k 1.1× 1.7k 1.4× 673 0.6× 1.6k 1.4× 619 0.6× 51 4.3k
Andrea Fuchsbichler Austria 34 1.2k 0.8× 1.9k 1.5× 2.4k 2.1× 1.8k 1.6× 2.1k 2.2× 63 5.1k
Jesús M. Bañales Spain 41 2.4k 1.6× 2.4k 2.0× 1.3k 1.1× 1.5k 1.4× 1.3k 1.4× 169 6.0k
Susumu Ohwada Japan 35 2.0k 1.3× 1.4k 1.2× 1.1k 0.9× 527 0.5× 437 0.5× 259 4.5k
Hideaki Enzan Japan 29 992 0.7× 719 0.6× 479 0.4× 677 0.6× 894 0.9× 180 3.2k
Carlo Spirlı̀ Italy 34 698 0.5× 1.5k 1.2× 702 0.6× 1.1k 1.0× 572 0.6× 61 2.8k
Alessia Omenetti United States 35 1.9k 1.3× 1.1k 0.9× 447 0.4× 1.8k 1.6× 1.8k 1.8× 58 4.3k

Countries citing papers authored by Véronique Barbu

Since Specialization
Citations

This map shows the geographic impact of Véronique Barbu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Barbu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Barbu more than expected).

Fields of papers citing papers by Véronique Barbu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Barbu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Barbu. The network helps show where Véronique Barbu may publish in the future.

Co-authorship network of co-authors of Véronique Barbu

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Barbu. A scholar is included among the top collaborators of Véronique Barbu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Barbu. Véronique Barbu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lascols, Olivier, et al.. (2019). Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease. Revista Española de Enfermedades Digestivas. 111(10). 775–788. 7 indexed citations
2.
Barbu, Véronique, et al.. (2018). Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment. Clinica Chimica Acta. 486. 122–128. 4 indexed citations
3.
Gautherot, Julien, Danièle Delautier, Marie-Anne Maubert, et al.. (2014). Phosphorylation of ABCB4 impacts its function: Insights from disease-causing mutations. Hepatology. 60(2). 610–621. 40 indexed citations
4.
El-Nujumi, A, et al.. (2012). Novel mutations in the Dubin–Johnson syndrome gene ABCC2/MRP2 and associated biochemical changes. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 49(6). 609–612. 17 indexed citations
5.
Eggelpoël, Marie-José Blivet-Van, Hamza Chettouh, Lætitia Fartoux, et al.. (2012). Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells. Journal of Hepatology. 57(1). 108–115. 147 indexed citations
6.
Debray, Dominique, Dominique Rainteau, Véronique Barbu, et al.. (2012). Defects in Gallbladder Emptying and Bile Acid Homeostasis in Mice With Cystic Fibrosis Transmembrane Conductance Regulator Deficiencies. Gastroenterology. 142(7). 1581–1591.e6. 57 indexed citations
7.
Cardot‐Bauters, C., Emmanuelle Leteurtre, L Leclerc, et al.. (2008). Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?. Clinical Endocrinology. 69(3). 506–510. 20 indexed citations
8.
Fouassier, Laura, Marc Beaussier, Eduardo Schiffer, et al.. (2007). Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(1). G25–G35. 48 indexed citations
9.
Desbois‐Mouthon, Christèle, Wulfran Cacheux, Véronique Barbu, et al.. (2006). Impact of IGF‐1R/EGFR cross‐talks on hepatoma cell sensitivity to gefitinib. International Journal of Cancer. 119(11). 2557–2566. 100 indexed citations
10.
Chignard, Nicolas, Martine Mergey, Véronique Barbu, et al.. (2005). VPAC1 Expression Is Regulated by FXR Agonists in the Human Gallbladder Epithelium *. Hepatology. 42(3). 549–557. 40 indexed citations
11.
Poupon, Raoul, Nicolas Chignard, Olivier Rosmorduc, Véronique Barbu, & Chantal Housset. (2004). La fonction biliaire et sa régulation. médecine/sciences. 20(12). 1096–1099. 9 indexed citations
12.
Verstuyft, Céline, Fan Li, Yong Zhang, et al.. (2003). Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations. Fundamental and Clinical Pharmacology. 17(3). 373–376. 64 indexed citations
13.
Corpechot, Christophe, Véronique Barbu, Dominique Wendum, et al.. (2002). Hepatocyte Growth Factor and c-Met Inhibition by Hepatic Cell Hypoxia. American Journal Of Pathology. 160(2). 613–620. 65 indexed citations
14.
Benoist, Stéphane, Riad Sarkis, Najim Chafaı̈, et al.. (2001). Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression. Journal of Hepatology. 35(2). 208–216. 5 indexed citations
15.
Fouassier, Laura, Thierry Chinet, Brigitte Robert, et al.. (1998). Endothelin-1 is synthesized and inhibits cyclic adenosine monophosphate- dependent anion secretion by an autocrine/paracrine mechanism in gallbladder epithelial cells.. Journal of Clinical Investigation. 101(12). 2881–2888. 30 indexed citations
16.
Flordellis, C S, Véronique Barbu, Haralambos Gavras, et al.. (1995). α2 Adrenergic Receptor Subtypes Expressed in Chinese Hamster Ovary Cells Activate Differentially Mitogen-activated Protein Kinase by a p21 Independent Pathway. Journal of Biological Chemistry. 270(8). 3491–3494. 42 indexed citations
17.
Capeau, Jacqueline, Véronique Barbu, Eric Chastre, et al.. (1994). Reduced insulin receptor expression and function in human colonic Caco-2 cells by ras and polyoma middle T oncogenes. Journal of Biological Chemistry. 269(28). 18686–18693. 10 indexed citations
18.
Hillaire, Sophie, et al.. (1994). Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology. 106(1). 239–242. 68 indexed citations
19.
Barbu, Véronique & François Dautry. (1989). Northern blot normalization with a 28S rRNA olinucleotide probe. Nucleic Acids Research. 17(17). 7115–7115. 347 indexed citations
20.
Barbu, Véronique, Charles Roux, R Dupuis, et al.. (1988). Cholesterol Prevents the Teratogenic Action of AY 9944: Importance of the Timing of Cholesterol Supplementation to Rats. Journal of Nutrition. 118(6). 774–779. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shotaro Sakisaka Breakdown of academic impact, for papers by Hitoshi Kohno Breakdown of academic impact, for papers by Siegfried Matern Breakdown of academic impact, for papers by Kenneth Dorko Breakdown of academic impact, for papers by Andrea Fuchsbichler Breakdown of academic impact, for papers by Jesús M. Bañales Breakdown of academic impact, for papers by Susumu Ohwada Breakdown of academic impact, for papers by Hideaki Enzan Breakdown of academic impact, for papers by Carlo Spirlı̀ Breakdown of academic impact, for papers by Alessia Omenetti
Rankless by CCL
2026